The Pros and Cons of Helicobacter pylori Treatment: A Focus on Cardiovascular Mortality
Open Access
- 15 January 2020
- journal article
- editorial
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 14 (1) , 1-2
Abstract
Cheal Wung Huh and Byung-Wook Kim. Gut and Liver 2020;14:1-2. https://doi.org/10.5009/gnl19193Keywords
This publication has 8 references indexed in Scilit:
- Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with HypertensionGut and Liver, 2020
- Helicobacter pylori Therapy for the Prevention of Metachronous Gastric CancerNew England Journal of Medicine, 2018
- Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort StudyAmerican Journal of Epidemiology, 2017
- Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designsBritish Journal of Clinical Pharmacology, 2016
- Cardiovascular outcomes associated with use of clarithromycin: population based studyBMJ, 2016
- Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?European Journal of Cancer, 2015
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsBMJ, 2014
- Clarithromycin Use and Risk of Death in Patients with Ischemic Heart DiseaseCardiology, 2010